Researchers developed a method that visualizes gene activity across an entire embryo with high spatial detail. The resulting ...
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Since 2008, Labroots has used its virtual events to connect a global network of scientists regarding the latest advancements in their fields. These virtual | Drug Discovery And Development ...
India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for treating Parkinson's disease and severe heart failure, advancing ...
Spring training might be over, but your sperm is just getting warmed up. While preparing for conception has historically been considered a woman’s burden, evolving research shows that infertility is ...
Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.
Japan's approval of the world’s first medical treatments using reprogrammed human cells signals a new era in regenerative ...
After a year of flipping an old pharmaceutical facility, FoodNerd opened a proprietary $5 million, 28,000 square foot plant in 2025 in Buffalo. The new factory allows FoodNerd to sprout its own seeds ...
In my clinical practice, many women planning pregnancy ask whether age can affect the health of their baby. Over the last few decades, it has become common for women to start families later because of ...
(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
Paris Maghoma has made an exciting start to life at Norwich City. Connor Southwell puts it under the microscope in his latest Canaries column.
MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in combination with androgen receptor (AR) inhibition in heavily ...